Nathan Revel
Co-founder, CEO
Nate brings the big-pharma blueprint to Exigyn. With a background driving strategy at Gilead and PwC, he knows what it takes to operate at a massive scale. But he also knows the pain of watching agile biotechs try to manage their clinical operations and burn rates through endless spreadsheets or rigid, generic software. He founded Exigyn to bridge that gap. Nate is here to arm life science companies with the enterprise-grade financial and operational tools they need—built specifically for the fast-paced realities of biotech.